Chronobiologic fluctuation of cyclophosphamide induced urinary bladder damage in mice.
Cyclophosphamide is the most widely used alkylating agent in clinical medicine. The usefulness of this drug is often limited by its propensity to produce hemorrhagic cystitis. To be active cyclophosphamide must be metabolized by the mixed function oxidase system. It has been previously demonstrated that the oncolytic activity and host lethality of cyclophosphamide are dependent upon circadian fluctuations. When cyclophosphamide is administered i.p. to male mice there is a dose dependent increase in urinary bladder weight. Histopathologic examination of these bladders revealed hemorrhage, edema, inflammation and stretching of the epithelial lining. When administered i.p. at 4-h intervals throughout a 24-h time period, cyclophosphamide produced maximum bladder damage when administered at 0500 and 1700 and little or no damage to the bladder when administered at 0100 or 1300. These studies suggest that cyclophosphamide induced cystitis, a toxicity resulting from the metabolic production of acrolein, may also be dependent upon chronobiologic fluctuations.
D000818:Animals; D002940:Circadian Rhythm; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000633:toxicity*; D008297:Male; D051379:Mice; D013997:Time Factors; D001743:Urinary Bladder / Q000293:injuries* / Q000473:pathology
D003520:Cyclophosphamide